SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 106 filers reported holding SURFACE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $293 | -14.1% | 419,495 | +1.0% | 0.00% | – |
| Q4 2022 | $341 | -99.9% | 415,270 | +11.2% | 0.00% | – |
| Q3 2022 | $388,000 | -66.2% | 373,510 | -46.7% | 0.00% | -100.0% |
| Q2 2022 | $1,149,000 | +984.0% | 700,787 | +3057.8% | 0.00% | – |
| Q4 2021 | $106,000 | -81.2% | 22,192 | -70.3% | 0.00% | – |
| Q3 2021 | $565,000 | -47.1% | 74,604 | -45.6% | 0.00% | -100.0% |
| Q1 2021 | $1,069,000 | -39.4% | 137,047 | -28.3% | 0.00% | 0.0% |
| Q4 2020 | $1,765,000 | +306.7% | 191,035 | +188.5% | 0.00% | 0.0% |
| Q2 2020 | $434,000 | -16.1% | 66,223 | -76.0% | 0.00% | 0.0% |
| Q1 2020 | $517,000 | -8.0% | 276,405 | -7.5% | 0.00% | 0.0% |
| Q4 2019 | $562,000 | -19.3% | 298,831 | -39.0% | 0.00% | 0.0% |
| Q3 2019 | $696,000 | -54.9% | 490,161 | -10.5% | 0.00% | -50.0% |
| Q2 2019 | $1,544,000 | -3.9% | 547,474 | +62.5% | 0.00% | 0.0% |
| Q1 2019 | $1,607,000 | +10.4% | 336,819 | -1.8% | 0.00% | 0.0% |
| Q4 2018 | $1,455,000 | -75.6% | 343,046 | -37.1% | 0.00% | -71.4% |
| Q3 2018 | $5,968,000 | -31.6% | 545,494 | +2.0% | 0.01% | -36.4% |
| Q2 2018 | $8,723,000 | – | 534,851 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |